ROsulord® sAfety for Patients with Dyslipidemia Study: A Non-interventional, Multicenter, Prospective, Observational Study in South Korea
Overall, these findings suggest that rosuvastatin is safe and effective in managing dyslipidemia in real-world clinical settings, providing clinicians with valuable insights into the benefits and risks associated with statin therapy in this patient population.
Authors
- Kyu-Hyung Ryu (ORCID: https://orcid.org/0000-0001-9329-2716)
- Jiyeong Park (ORCID: https://orcid.org/0009-0001-5327-3243)
- Eung Ju Kim (ORCID: https://orcid.org/0000-0003-2322-6267)
- Hee-Seok Kim (ORCID: https://orcid.org/0000-0003-0099-7413)
- Jong‐Chan Youn (ORCID: https://orcid.org/0000-0003-0998-503X)
- Ji Eun Jeong (ORCID: https://orcid.org/0000-0002-3036-6818)
- Sung Hea Kim (ORCID: https://orcid.org/0000-0001-5809-7958)
- Sang-Jin Han
- Do Young Kim
Institutions
- Eulji University (KR)
- Konkuk University (KR)
- Korea University Medical Center (KR)
- National University of Management (KH)
- Chong Kun Dang Bio (South Korea) (KR)
- Ajou University Hospital (KR)
- Hallym University Sacred Heart Hospital (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Cardiology and Therapy
- Published
- 2024-11-23
- DOI
- https://doi.org/10.1007/s40119-024-00391-4
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.57